(Albany, USA) DelveInsight’s “Cancer Therapy Market Insights, Competitive Landscape, and Market Forecast – 2030” report provides the current and forecast market outlook, forthcoming device innovation, challenges, market drivers and barriers. The report also covers the major emerging products and key Cancer Therapy companies actively working in the market.
Request for sample report @ Global Cancer Therapy Market
Some facts of the Cancer Therapy Market Report are:
- DelveInsight Analysis: The Global Cancer Therapy market size is anticipated to grow with a CAGR of ~9% during the forecasted period (2024-2030).
- As per DelveInsight’s assessment, The Cancer Therapy market is witnessing a positive market growth owing to the factors such as increasing prevalence of various cancers, rise in external factors contributing in cancer development, growing popularity of precision medicine and targeted therapy, technological advancements in product development and others.
- Cancer Therapy Companies working in the market are GlaxoSmithKline, Eli Lilly & Company, F. Hoffmann-La Roche Ltd, AbbVie Inc., Amgen Inc, Sanofi, Merck & Co., Inc, Novartis AG, Pfizer Inc, AstraZeneca, Bristol Myers Squibb., Gilead Sciences, Inc., Janssen Global Services, LLC, Elekta AB, Varian Medical Systems, Inc., Accuray Incorporated, Pyrexar Medical, Eckert & Ziegler, IBA, Panacea Medical Technologies Pvt. Ltd.and others.
- In October 15, 2021, the US FDA approved atezolizumab (Tecentriq) by Genentech, Inc. for adjuvant treatment following resection and platinum-based chemotherapy in patients with stage II to IIIA non-small cell lung cancer (NSCLC).
- In August 2021, Bristol Myers Squibbs received the conditional marketing authorization for Abecma (idecabtagene vicleucel) by the European Commission for the treatment of adult patients with relapsed and refractory multiple myeloma. It is a first-in-class B-cell maturation antigen (BCMA)-directed chimeric antigen receptor (CAR) T cell immunotherapy.
Cancer Therapy Overview
Cancer therapy encompasses a range of treatments designed to target and eliminate cancer cells while minimizing damage to normal tissues. Common approaches include surgery, chemotherapy, radiation therapy, immunotherapy, targeted therapy, and hormone therapy.
Surgery involves removing the tumor physically and is often used when cancer is localized. Chemotherapy uses drugs to kill rapidly dividing cells, but it can affect healthy cells too, leading to side effects. Radiation therapy utilizes high-energy rays to destroy cancer cells and shrink tumors. Both are standard for many cancers but can harm nearby healthy tissue.
Immunotherapy boosts the body’s immune system to recognize and attack cancer cells, while targeted therapies are designed to attack specific genetic changes in cancer cells, reducing damage to normal cells. Hormone therapy slows or stops cancers like breast and prostate cancer that grow in response to hormones.
Emerging treatments include CAR-T cell therapy and precision medicine, where treatments are tailored to an individual’s genetic makeup, enhancing effectiveness and minimizing side effects. The choice of therapy depends on cancer type, stage, and the patient’s overall health. Many patients receive a combination of therapies for optimal results.
To know more about why North America is leading the market growth in the Cancer Therapy market, get a snapshot of the report @ Cancer Therapy Market Trends
Recent Developments in the Cancer Therapy Market Report
- In October 15, 2021, the US FDA approved atezolizumab (Tecentriq) by Genentech, Inc. for adjuvant treatment following resection and platinum-based chemotherapy in patients with stage II to IIIA non-small cell lung cancer (NSCLC).
- In August 2021, Bristol Myers Squibbs received the conditional marketing authorization for Abecma (idecabtagene vicleucel) by the European Commission for the treatment of adult patients with relapsed and refractory multiple myeloma. It is a first-in-class B-cell maturation antigen (BCMA)-directed chimeric antigen receptor (CAR) T cell immunotherapy.
- In June 2021, the US FDA granted the product approval to Elekta AB’s Elekta Harmony radiation therapy system to deliver radiotherapy in the treatment of various cancers such as lung, prostate, and breast cancers.
Cancer Therapy Market Insights
The cancer therapy market is driven by the increasing incidence of cancer worldwide. According to the GLOBOCAN 2020 report, 19.3 million new cancer cases and 10 million cancer-related deaths were recorded globally. Lung cancer led in fatalities, followed by colorectal, liver, stomach, and breast cancers. The need for effective treatment solutions has led to the extensive use of surgery, chemotherapy, and radiation therapy, all of which provide both curative and palliative benefits.
Additionally, the growing adoption of precision medicine is enhancing the cancer therapy market. Precision medicine allows for personalized treatments based on genetic profiling, improving outcomes through targeted therapies. Techniques like RNA and next-generation sequencing have further advanced tumor typing and therapy development. Investments in cancer research, such as those by the National Cancer Institute (NCI) in the U.S., are also propelling market growth.
However, challenges such as side effects and the high cost of cancer therapies in low- and middle-income countries could hinder growth. Despite disruptions caused by the COVID-19 pandemic, the cancer therapy market is expected to recover and grow steadily, driven by innovations in targeted therapies and increased awareness globally.
To read more about the latest highlights related to Cancer Therapy, get a snapshot of the key highlights entailed in the Cancer Therapy Treatment Landscape
Key Players in the Cancer Therapy Market
Some of the key market players operating in the Cancer Therapy market include- GlaxoSmithKline, Eli Lilly & Company, F. Hoffmann-La Roche Ltd, AbbVie Inc., Amgen Inc, Sanofi, Merck & Co., Inc, Novartis AG, Pfizer Inc, AstraZeneca, Bristol Myers Squibb., Gilead Sciences, Inc., Janssen Global Services, LLC, Elekta AB, Varian Medical Systems, Inc., Accuray Incorporated, Pyrexar Medical, Eckert & Ziegler, IBA, Panacea Medical Technologies Pvt. Ltd.and others.
Scope of the Cancer Therapy Market Report
- Coverage: Global
- Study Period: 2021–2030
- Cancer Therapy Market Segmentation Therapy Type: Chemotherapy, Radiation Therapy, Hormonal Therapy, Targeted Therapy, And Others
- Cancer Therapy Market Segmentation By Cancer Type: Breast Cancer, Lung Cancer, Prostate Cancer, Blood Cancers, And Others
- Cancer Therapy Market Segmentation by END User type: Hospitals, Specialty Clinics, And others.
- Cancer Therapy Market Segmentation By Geography: North America, Europe, Asia-Pacific, and Rest of the World
- Key Cancer Therapy Companies: GlaxoSmithKline, Eli Lilly & Company, F. Hoffmann-La Roche Ltd, AbbVie Inc., Amgen Inc, Sanofi, Merck & Co., Inc, Novartis AG, Pfizer Inc, AstraZeneca, Bristol Myers Squibb., Gilead Sciences, Inc., Janssen Global Services, LLC, Elekta AB, Varian Medical Systems, Inc., Accuray Incorporated, Pyrexar Medical, Eckert & Ziegler, IBA, Panacea Medical Technologies Pvt. Ltd. and others.
- Porter’s Five Forces Analysis, Product Profiles, Case Studies, KOL’s Views, Analyst’s View
To know more about why North America is leading the market growth in the Cancer Therapy market, get a snapshot of the report @ Cancer Therapy Market Trends
Cancer Therapy KOL – Views and Insights
To keep up with the market trends, we take KOLs and SME’s opinions working in the Cancer Therapy domain through primary research to fill the data gaps and validate our secondary research. Their opinion helps to understand and validate current and emerging Cancer Therapy market trends. This will support the clients in making informed business decisions by identifying the overall scenario of the market and the unmet needs.
Reasons To Buy Cancer Therapy Market Report:
- The report will help develop business strategies by understanding the latest trends and changing treatment dynamics driving the Cancer Therapy Market.
- To understand the existing market opportunity in varying geographies and the growth potential over the coming years.
- Identifying strong upcoming players in the market will help devise strategies that will help get ahead of competitors.
- Detailed analysis and ranking of potential current and emerging therapies under the conjoint analysis section to provide visibility around leading classes.
- To understand the perspective of Key Opinion Leaders around the accessibility, acceptability, and compliance-related challenges of existing treatment to overcome barriers in the future.
- Detailed insights on the unmet needs of the existing market so that the upcoming players can strengthen their development and launch strategy.
Which key players in the Cancer Therapy market are set to emerge as the trendsetter explore @ Cancer Therapy Market Landscape
Table of Contents
1. Cancer Therapy Market Report Introduction
2. Cancer Therapy Market Executive Summary
3. Competitive Landscape
4. Regulatory Analysis
5. Cancer Therapy Market Key Factors Analysis
6. Cancer Therapy Market Porter’s Five Forces Analysis
7. Cancer Therapy Market Layout
8. Cancer Therapy Market Company and Product Profiles
9. KOL Views
10. Project Approach
11. About DelveInsight
About DelveInsight
DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance. It also offers Healthcare Consulting Services, which benefits in market analysis to accelerate business growth and overcome challenges with a practical approach.
Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Ankit Nigam
Email: Send Email
Phone: +14699457679
Address:304 S. Jones Blvd #2432
City: Albany
State: New York
Country: United States
Website: https://www.delveinsight.com/consulting